申请人:Bristol-Myers Squibb Co.
公开号:US05011851A1
公开(公告)日:1991-04-30
Heterocyclic acids and esters useful as inhibitors of mammalian blood platelet aggregation characterized by Formula I or II are disclosed. HET.sub.1 --(CH.sub.2).sub.n CO.sub.2 R (I) ##STR1## Formula I compounds are those wherein n is 6-9, R is hydrogen, lower alkyl or an alkali metal ion, and HET.sub.1 is the heterocyclic radical 4,5-diphenyl-1H-imidazol-2-yl. Formula II compounds are those wherein R.sub.1 is hydrogen, lower alkyl or an alkali metal ion, and the radical --OCH.sub.2 CO.sub.2 R is attached in the 3 or 4 ring position; and HET.sub.2 is the heterocyclic radical 4,5-diphenyl-1H-imidazol-2-yl. Formula VIII compounds are those wherein R.sub.1 is hydrogen, lower alkyl or an alkali metal ion, and the radical --OCH.sub.2 CO.sub.2 R is attached in the 3 or 4 ring position.
本发明揭示了作为哺乳动物血小板聚集抑制剂的杂环酸和酯,其特征在于具有式I或II。HET.sub.1 --(CH.sub.2).sub.n CO.sub.2 R (I)。公式I化合物中,n为6-9,R为氢、较低的烷基或碱金属离子,HET.sub.1为杂环基4,5-二苯基-1H-咪唑-2-基。公式II化合物中,R.sub.1为氢、较低的烷基或碱金属离子,基团--OCH.sub.2 CO.sub.2 R附着在3或4环位置;HET.sub.2为杂环基4,5-二苯基-1H-咪唑-2-基。公式VIII化合物中,R.sub.1为氢、较低的烷基或碱金属离子,基团--OCH.sub.2 CO.sub.2 R附着在3或4环位置。